{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"66.0","upperLimit":"71.4","value":"68.7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1151"}],"units":"Participants"}],"description":"Sensitivity of the VES-13 questionnaire measured as percentage of participants with a positive VES-13 test among patients with a positive MGA. VES-13 is a self-administered questionnaire that was completed during the first visit after enrollment. For 3 pre-identified centers, patients filled in the questionnaire at the following geriatric visit. VES-13 consisted of 4 groups of questions: age, self-perceived health, difficulties to perform 6 specific activities, and difficulties to perform daily living tasks due to health concerns. The score ranged from 0 to 10 and a score \\>=3 was considered to show impairment.\n\nMultidimensional geriatric assessment (MGA): see measure description for primary outcome.","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients older than 70 years and included either before any first-line treatment, or between any two steps of a pre-defined first-line treatment sequence (chemotherapy, endocrine therapy, targeted treatment, surgery or radiotherapy) for various types of histologically-confirmed cancer (colon, lung, upper aero digestive tract (UAT)/head and neck, breast, prostate, and non-Hodgkin's lymphomas (NHL)), and for whom G8 as well as at least one instrument of the multidimensional assessment were available.","id":"OG000","title":"Eligible Patients Assessable for the Primary Outcome Measure"}],"paramType":"NUMBER","populationDescription":"Eligible Patients Assessable for the Primary Outcome Measure AND with a positive VES-13","reportingStatus":"POSTED","timeFrame":"at inclusion","title":"Sensitivity of the VES-13 Questionnaire","type":"SECONDARY","unitOfMeasure":"% of Participants with a positive VES13"}